Emcure Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Emcure Pharmaceuticals Ltd · Outcome · 03 Nov 2026, 7:11 pm
Emcure Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 28,205 (+24.3% YoY | +9.3% QoQ) ■ EBITDA: 5,878 (+23.6% YoY | +10.4% QoQ) ■ EBITDA Margin (%): 20.8 (-11 bps YoY | +21 bps QoQ) ■ PAT: 3,256 (+33.7% YoY | +10.7% QoQ) ■ EPS (INR): 17.1 (+33.4% YoY | +10.6% QoQ)
Original exchange filing (PDF)
More announcements from Emcure Pharmaceuticals Ltd
- Intimation of Cancellation of schedule of Analyst / Investor Meeting(s) scheduled on November 16, 2026 · 15 Nov 2026
- Transcript of Earnings Call - Q2 FY27 held on Tuesday, November 03, 2026 at 4:00 p.m. (IST) · 06 Nov 2026
- Intimation of schedule of Analyst/Investor Meeting dated Monday, November 16, 2026 · 06 Nov 2026
- Intimation of schedule of Analyst/Investor Meeting on Monday, November 16, 2026 · 06 Nov 2026
- Audio recording of Earnings Call - Q2 FY27 · 04 Nov 2026
- Presentation on Unaudited Financial Results for the quarter ended September 30, 2026 · 03 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026 · 03 Nov 2026
- Emcure Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 03 Nov 2026
